Cargando…
Single-Agent Thalidomide for Treatment of Malignant Paraganglioma of the Organ of Zuckerkandl
The standard of care for benign pheochromocytomas and paragangliomas is surgical resection; however, there is no definitive curative or standard therapy for the treatment of malignant pheochromocytomas or paragangliomas. Current therapeutic options include surgical resection, chemotherapy (CVD thera...
Autores principales: | Shindorf, Mackenzie L., Chaudhuri, Prabir K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6748205/ https://www.ncbi.nlm.nih.gov/pubmed/31582983 http://dx.doi.org/10.1155/2019/7185973 |
Ejemplares similares
-
Pheochromocytoma of the organ of Zuckerkandl
por: Le, Hoang Di Thu, et al.
Publicado: (2020) -
Dissecting a diagnostic enigma: Hypertension in a young patient from an organ of Zuckerkandl paraganglioma
por: Najjar, Reabal, et al.
Publicado: (2023) -
Ectopic pheochromocytoma or paraganglioma of the ZUCKERKANDL organ: A case report and review of the literature
por: Zongo, Nayi, et al.
Publicado: (2019) -
Laparoscopic resection of a large clinically silent paraganglioma at the organ of Zuckerkandl: a rare case report and review of the literature
por: Ren, Xiang, et al.
Publicado: (2020) -
Co-occurrence of pheochromocytoma and paraganglioma of the organ of
Zuckerkandl resected simultaneously by laparoscopy: a rare case report and
literature review
por: Chang, Zhi, et al.
Publicado: (2023)